Vysokospecializovany odborny ustav geriatricky sv. Lukasa v Kosiciach, n.o.
- Address
- Strojarenska 13, Stare Mesto, 040 01 Košice, Slovakia
Cardiovascular and Metabolic Research
Clinical trial activity at Vysokospecializovany odborny ustav geriatricky sv. Lukasa v Kosiciach, n.o. focuses on cardiovascular diseases alongside nutritional and metabolic diseases, with studies centered on type 2 diabetes, hypertension, and established cardiovascular disease. The research is aimed at evaluating new treatment approaches that may improve heart-related outcomes and support better disease control in people with multiple chronic conditions.
- Testing new therapies for people living with type 2 diabetes, high blood pressure, and cardiovascular disease
- Assessing whether treatment combinations can improve protection against serious heart-related events
This area reflects a strong interest in reducing the burden of interconnected heart and metabolic conditions through more effective care strategies.
Kidney and Diabetes Studies
The site is also involved in research on chronic kidney disease within the broader context of type 2 diabetes and excess body weight. These trials are designed to explore whether new therapies can slow kidney damage and improve markers linked to disease progression, supporting earlier and more effective intervention in people at risk of worsening renal health.
- Evaluating treatments for chronic kidney disease in people with type 2 diabetes
- Studying whether new combinations can improve kidney-related health indicators
Research in this field connects metabolic disease management with kidney protection, highlighting an important clinical focus for older adults and patients with complex long-term conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Boehringer Ingelheim Espana S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vysokospecializovany odborny ustav geriatricky sv. Lukasa v Kosiciach, n.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Cagrilintide and Semaglutide in Patients with Type 2 Diabetes, Chronic Kidney Disease, and Overweight or Obesity | Novo Nordisk A/S | Phase II | Not Recruiting | Apr 2024 | Oct 2025 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 1 | Unknown | 2025-10-15 | 2025-10-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.